Approval is granted from 2007 through 2009.

The French Ministry for Higher Education and Research named Cobra Biomanufacturing an approved research and development service provider. This allows companies subject to the French General Tax Code to take advantage of the research and development tax credit (Le Crédit d’Impôt Recherche, or CIR).

As a result, according to Cobra officials,  French companies that have outsourced R&D to Cobra will be able to benefit from the CIR. This approval is granted for 2007, 2008, and 2009. The tax credit limit was €16 million per company per year in 2007.

“This new status will allow Cobra’s clients in France to easily take advantage of the tax breaks the French Government has made available,” explains Simon Saxby, COO of Cobra Biomanufacturing. “Cobra is already an active player in the French market, and this development will further improve our offering to customers.”

Previous articleBAC and Octapharma to Develop Custom Ligand for Recombinant Plasma Protein
Next articleSilence Therapeutics and AstraZeneca Partner to Advance siRNA Drug Delivery Techniques